Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Adrenal insufficiency epidemiology and demographics

Introduction

Overview

Overview

Adrenal insufficiency is a rare disorder. It may present in patients of all age groups. The incidence of autoimmune adrenalitis is more common in females in the age groups of 30 to 50 compared to males. Whereas, adrenal crisis does not show any female to male predilection. The most common cause of primary adrenal insufficiency in the developed world is autoimmune adrenalitis. Whereas, in the developing world it is Tuberculosis. The most common cause of central adrenal insufficiency is chronic glucocorticoid use.

Epidemiology and Demographics

Epidemiology and Demographics

Incidence

  • The incidence of adrenal insufficiency is approximately 0.8 new cases per 100,000 individuals per year individuals in the developed world. [1]
  • The incidence of adrenal insufficiency in Europe is approximately 4.4 to 6.2 new cases per 100,000 individuals per year .[2]

Prevalence

Case-fatality rate/Mortality rate

Age

Race

Gender

  • Females are more commonly affected by adrenal insufficiency than males. The female to male ratio is approximately 2 to 1 for primary adrenal insufficiency. [15]
  • Acute adrenal crisis affects males and females equally. [16]

Region

Developed Countries

Worldwide, the most common cause of primary adrenal insufficiency was Tuberculosis. However, since the 1950s the incidence of autoimmune adrenalitis has been rising. Now, the most common cause of primary adrenal insufficiency in the developed world is autoimmune adrenalitis. [18]

Developing Countries

The most common cause of primary adrenal insufficiency in the developing world is Tuberculosis. [19]

References

References

  1. ↑ Melmed, Shlomo (2020). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBNΒ 9780323555968.
  2. ↑ Elshimy G, Alghoula F, Jeong JM. PMIDΒ 29763143. Missing or empty |title= (help)
  3. ↑ Melmed, Shlomo (2020). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBNΒ 9780323555968.
  4. ↑ Laureti S, Vecchi L, Santeusanio F, Falorni A (May 1999). “Is the prevalence of Addison’s disease underestimated?”. J Clin Endocrinol Metab. 84 (5): 1762. doi:10.1210/jcem.84.5.5677-7. PMIDΒ 10323417.
  5. ↑ Erichsen MM, LΓΈvΓ₯s K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES (December 2009). “Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry”. J Clin Endocrinol Metab. 94 (12): 4882–90. doi:10.1210/jc.2009-1368. PMIDΒ 19858318.
  6. ↑ Olafsson AS, Sigurjonsdottir HA (January 2016). “INCREASING PREVALENCE OF ADDISON DISEASE: RESULTS FROM A NATIONWIDE STUDY”. Endocr Pract. 22 (1): 30–5. doi:10.4158/EP15754.OR. PMIDΒ 26437215.
  7. ↑ “Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality – ScienceDirect”.
  8. ↑ “Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain – Regal – 2001 – Clinical Endocrinology – Wiley Online Library”.
  9. ↑ Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (February 2001). “Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group”. Lancet. 357 (9254): 425–31. doi:10.1016/s0140-6736(00)04006-x. PMIDΒ 11273062.
  10. ↑ Elshimy G, Alghoula F, Jeong JM. PMIDΒ 29763143. Missing or empty |title= (help)
  11. ↑ Øksnes M, Husebye ES (December 2023). “Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults”. J Clin Endocrinol Metab. 109 (1): 269–278. doi:10.1210/clinem/dgad402. PMCΒ 10735307 Check |pmc= value (help). PMIDΒ 37450570 Check |pmid= value (help).
  12. ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland HJ, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP, Nicolaides NC, Chrousos GP, Charmandari E. PMIDΒ 25905309. Missing or empty |title= (help)
  13. ↑ Elshimy G, Alghoula F, Jeong JM. PMIDΒ 29763143. Missing or empty |title= (help)
  14. ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland HJ, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP, Nicolaides NC, Chrousos GP, Charmandari E. PMIDΒ 25905309. Missing or empty |title= (help)
  15. ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland HJ, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP, Nicolaides NC, Chrousos GP, Charmandari E. PMIDΒ 25905309. Missing or empty |title= (help)
  16. ↑ Elshimy G, Alghoula F, Jeong JM. PMIDΒ 29763143. Missing or empty |title= (help)
  17. ↑ Elshimy G, Alghoula F, Jeong JM. PMIDΒ 29763143. Missing or empty |title= (help)
  18. ↑ Gardner, David (2018). Greenspan’s basic & clinical endocrinology. New York, N.Y: McGraw-Hill Education LLC. ISBNΒ 9781259589287.
  19. ↑ Gardner, David (2018). Greenspan’s basic & clinical endocrinology. New York, N.Y: McGraw-Hill Education LLC. ISBNΒ 9781259589287.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2] Muhammad Saad, M.B.B.S.[3]